DexCom, Inc. (DXCM) vs Zimmer Biomet Holdings, Inc. (ZBH)
DexCom, Inc. and Zimmer Biomet Holdings, Inc. are both Medical Devices companies. DexCom, Inc. is the larger, with a market value of $33.0B against $17.1B — 1.9× the size. Zimmer Biomet Holdings, Inc. trades at the lower P/E: 22.0× against 33.4×. DexCom, Inc. grew revenue faster over the last twelve months: 15.5% against 8.62%. DexCom, Inc. has the higher net margin (20.1% vs 9.48%) and the higher return on invested capital (37.1% vs 3.82%). Across the 22 metrics below, DexCom, Inc. leads on 13 and Zimmer Biomet Holdings, Inc. on 9.
Valuation
Profitability
| Metric | DXCM | ZBH | Medical Devices median |
|---|---|---|---|
| Gross margin | 62.47% | 69.87% | 56.01% |
| Operating margin | 22.92% | 14.16% | (15.03%) |
| Net margin | 20.12% | 9.48% | (20.40%) |
| Free cash flow margin | 28.27% | 12.18% | (7.24%) |
| Return on equity | 38.49% | 6.41% | (15.32%) |
| Return on assets | 14.51% | 3.53% | (19.72%) |
| Return on invested capital | 37.13% | 3.82% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack